Issue No 01+02/2005
| Clin. Lab. 2005;51:1-4 Abstract |
REVIEW ARTICLE
What Cardiologists do Need to Know about Procalcitonin |
| Clin. Lab. 2005;51:5-9 Abstract |
REVIEW ARTICLE
The Use of B-type Natriuretic Peptide in the Diagnosis of Acute Dyspnoea |
| Clin. Lab. 2005;51:11-19 Abstract |
ORIGINAL ARTICLE
Serum Hyaluronic Acid Levels are Elevated in Arthritis Patients, but Normal and Not Associated with Clinical Data in Patients with Fibromyalgia Syndrome |
| Clin. Lab. 2005;51:21-29 Abstract |
REVIEW ARTICLE
Evolution of the Parathyroid Hormone (PTH) Assay - Importance of Circulating PTH Immunoheterogeneity and of its Regulation |
| Clin. Lab. 2005;51:31-41 Abstract |
ORIGINAL ARTICLE
The Abbott Architect c8000: Analytical Performance and Productivity Characteristics of a New Analyzer Applied to General Chemistry Testing |
| Clin. Lab. 2005;51:43-45 Abstract |
ORIGINAL ARTICLE
Clinical Significance of Hematocrit Interference in the Tacrolimus II Microparticle Enzyme Immunoassay: A Tentative Approach |
| Clin. Lab. 2005;51:47-48 Abstract |
LETTER TO THE EDITOR
Sealing Ability of a Glass Ampoule |
| Clin. Lab. 2005;51:49-53 Abstract |
ORIGINAL ARTICLE
Evaluation of Alkaline Phosphatase Activity Assay for the Reflotron® System after Substitution of the Comparison Method |
| Clin. Lab. 2005;51:63-72 Abstract |
REVIEW ARTICLE
Rationale for Testing the Cardiovascular Risk for Patients with COX-2 Inhibitors on the Basis of Biomarker NT-proBNP |
| Clin. Lab. 2005;51:73-83 Abstract |
REVIEW ARTICLE
Rationale zur Testung des kardiovaskulären Risikos bei Patienten mit COX-2-Hemmern anhand des Biomarkers NT-proBNP |
